Moffitt Cancer Center Researchers Recognized For Advances In Radiation Oncology

November 23, 2009

Tampa, FL Moffitt Cancer Center research has been honored during the American Society for Radiation Oncology (ASTRO) at the 51st annual meeting held Nov.1-5 at McCormick Place West in Chicago.

The meeting hosted celebratory events for accomplished researchers who have made advances in radiation oncology. Moffitt physicians from the Radiation Oncology Program have been recognized for advances in cancer care.

Steven Finkelstein, M.D., and Catherine Park, M.D., M.P.H., were honored for their accomplishments in the advancements in the use of radiation therapy for sarcoma and breast cancer treatment.

Finkelstein was honored as the top clinical practice recipient of the Resident Clinical and Basic Science Research Award. This honor was granted to the top three resident-authors of significant works in physics, biology and clinical practice. He presented his clinical and translational abstract on the use of radiation to improve immunotherapy for the treatment of high-risk sarcoma patients. Finkelstein’s work focuses on attacking cancer cells by combining radiation therapy with immunotherapy.

Finkelstein’s research was also discussed at the Best of ASTRO session where meeting organizers explained the importance of their work.

Park was the second place winner in the radiation physics category. She presented her abstract on the use of accelerated partial breast irradiation, which is used to treat part of the breast in the early stages of breast cancer. This study was undertaken to see if the use of fiducial markers, for image guided radiation therapy, can better localize target areas to reduce toxicity and enhance accuracy of treatment.

Moffitt researchers were awarded a quarter of the distributed ASTRO Annual Meeting Travel Grants. The grants were distributed for important research in sarcoma, breast, lung and GI cancer therapy.

“This is a stellar accomplishment for our training program, and it speaks to the strength of the clinical research being done by the Radiation Oncology faculty,” said Dr. Eleanor Harris, residency program director from the Department of Radiation Oncology.

Radiation Oncology members who presented their work in educational and research sessions to thousands of renowned medical professionals included:

  • Irfan M. Ahmed, M.D.
  • Thomas I. Dilling, M.D.
  • Dan Fernandez, M.D., Ph.D.
  • Steven Finkelstein, M.D.
  • Jessica M. Freilich
  • Valeria M. Gironda, M.D.
  • Eleanor Harris, M.D.
  • Catherine Park, M.D.
  • Jakob Pritz
  • Chad Rusthoven
  • Ravi Shridhar, M.D., Ph.D.
  • Craig W. Stevens, Ph.D., M.D.
  • Andy M. Trotti, M.D.
  • Michael Yu, M.D.

About the American Society for Radiation Oncology

ASTRO is the largest radiation oncology society in the world, with more than 10,000 members who specialize in treating patients with radiation therapies. As the leading organization in radiation oncology, biology and physics, the Society is dedicated to improving patient care through education, clinical practice, advancement of science and advocacy. For more information on radiation therapy, visit RT Answers. To learn more about ASTRO, visit ASTRO.

About Moffitt Cancer Center

Located in Tampa, Florida, Moffitt Cancer Center  is an NCI Comprehensive Cancer Center — a designation that recognizes Moffitt’s excellence in research and contributions to clinical trials, prevention and cancer control. Moffitt currently has 15 affiliates in Florida, one in Georgia and two in Puerto Rico. Additionally, Moffitt is a member of the National Comprehensive Cancer Network, a prestigious alliance of the country’s leading cancer centers, and is listed in U.S. News & World Report as one of “America’s Best Hospitals” for cancer. Moffitt’s sole mission is to contribute to the prevention and cure of cancer.